Medtech in a Minute: Kicking off 2023 with Spinoffs, M&A, and More

Zimmer Biomet 'Embodies' the M&A Spirit
Zimmer Biomet is already flexing its M&A muscles in 2023 with a deal valued at $275 million. The company has agreed to pay $155 million at closing and up to an additional $120 million in milestone payments over a three-year period for a private company called Embody. The acquisition is expected to strengthen Zimmer Biomet's growing sports medicine portfolio and also supports the continued transformation of Zimmer Biomet.